Changing lives through cell therapy

At Kite, we are on a mission to utilize cell therapy to pursue a cure for cancer. We aim to ensure our cell therapy clinical trials reflect our global community and that our innovative treatments reach every patient who needs it. Our work is more than just developing treatments, it's about giving hope of a healthier future for all.

Changing lives through cell therapy

What is cell therapy?

Cells can change over time and sometimes in harmful ways, but cell therapy can help. It is an innovative treatment that uses your own cells to help fight or prevent a disease. There are many types of cells that can be changed a bit and used for this treatment. So far, this kind of therapy has shown promise in conditions like blood cancer, bone marrow cancer, or other diseases that stop your body from making healthy cells.

Our approach to cell therapy in 3 steps

Every cell therapy Kite provides is specially made for each patient, using the strength of your own body's defense system to find and fight cancer.

Here's how our CAR T-cell therapy creation process works:

Step 1:

Collect T cells from
your body

Step 2:

Change the T cells
into CAR T-cells

Step 3:

Return CAR T-cells back into your body to help treat illnesses

What therapeutic areas are we researching?

At Kite, we’ve been effectively treating certain types of blood cancers and we believe cell therapy can help with other tough-to-treat illnesses too.

Blood cancers

We're working hard to lead the way in treating blood cancers like large B-cell lymphoma, follicular lymphoma, and multiple myeloma. Our goal is to improve treatment outcomes, reduce side effects, and increase accessibility. We are currently investigating CAR T-cell therapy, an innovative therapy that targets 2 antigens at once, offering a promising treatment alternative for patients with large B-cell lymphoma.

Solid tumors

In the past, it’s been difficult to treat solid tumors using CAR T-cell therapy. But we're not giving up. Right now, we're researching ways to use cell therapy to potentially treat liver cancers, specifically hepatocellular cancer, brain cancers such as glioblastoma, and cancers affecting the nerves like neuroblastoma.

Autoimmune diseases

We think the potential of CAR T-cell therapy can treat more than cancer, which is why we're now investigating its potential benefits for autoimmune diseases. These are conditions where your body's immune system mistakenly attacks your own body. Some examples are systemic lupus erythematosus (most common type of lupus that affects many parts of the body), lupus nephritis (lupus that affects the kidneys), scleroderma (a disease that results in hard, tight skin), and myositis (inflammation of the muscles).

Championing diversity and inclusion in clinical trials

Recognizing the critical importance of having a diverse patient population, Kite strives to make all clinical trials reflect the real-world patient population. This significantly enhances the understanding of how individual genetic variations can affect treatment outcomes. Our commitment to diversity in clinical trials could change the cell therapy landscape and ensure more effective, personalized treatments for patients globally.